NO915084L - Fremgangsmaate ved fremstilling av human interleukin-5 receptor - Google Patents

Fremgangsmaate ved fremstilling av human interleukin-5 receptor

Info

Publication number
NO915084L
NO915084L NO91915084A NO915084A NO915084L NO 915084 L NO915084 L NO 915084L NO 91915084 A NO91915084 A NO 91915084A NO 915084 A NO915084 A NO 915084A NO 915084 L NO915084 L NO 915084L
Authority
NO
Norway
Prior art keywords
receptor
human interleukin
procedure
manufacturing human
preparation
Prior art date
Application number
NO91915084A
Other languages
English (en)
Norwegian (no)
Other versions
NO915084D0 (no
Inventor
Rene Devos
Walter Fiers
Geert Plaetinck
Jan Tavernier
Jose Van Der Heyden
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO915084D0 publication Critical patent/NO915084D0/no
Publication of NO915084L publication Critical patent/NO915084L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO91915084A 1990-12-27 1991-12-23 Fremgangsmaate ved fremstilling av human interleukin-5 receptor NO915084L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP90811030 1990-12-27
EP91810327 1991-04-30

Publications (2)

Publication Number Publication Date
NO915084D0 NO915084D0 (no) 1991-12-23
NO915084L true NO915084L (no) 1992-06-29

Family

ID=26127858

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91915084A NO915084L (no) 1990-12-27 1991-12-23 Fremgangsmaate ved fremstilling av human interleukin-5 receptor

Country Status (16)

Country Link
EP (1) EP0492214A3 (en:Method)
JP (1) JP2554418B2 (en:Method)
KR (1) KR920012440A (en:Method)
AR (1) AR246310A1 (en:Method)
AU (1) AU647560B2 (en:Method)
CA (1) CA2058003A1 (en:Method)
FI (1) FI916067L (en:Method)
HU (1) HUT59725A (en:Method)
IE (1) IE914548A1 (en:Method)
IL (1) IL100470A0 (en:Method)
MX (1) MX9102767A (en:Method)
NO (1) NO915084L (en:Method)
NZ (1) NZ241094A (en:Method)
PT (1) PT99929A (en:Method)
TW (1) TW280833B (en:Method)
YU (1) YU199691A (en:Method)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5453491A (en) * 1990-09-11 1995-09-26 Kiyoshi Takatsu Murine interleukin-5 receptor
US5856097A (en) 1992-03-04 1999-01-05 The Regents Of The University Of California Comparative genomic hybridization (CGH)
US5668110A (en) * 1995-06-07 1997-09-16 Affymax Technologies N.V. Peptides and compounds that bind to the IL-5 receptor
US5654276A (en) * 1995-06-07 1997-08-05 Affymax Technologies N.V. Peptides and compounds that bind to the IL-5 receptor
US5683983A (en) * 1995-06-07 1997-11-04 Glaxo Group Limited Peptides and compounds that bind to the IL-5 receptor
US5677280A (en) * 1995-06-07 1997-10-14 Glaxo Group Limited Peptides and compounds that bind to the IL-5 receptor
WO1997010354A1 (en) 1995-09-11 1997-03-20 Kyowa Hakko Kogyo Co., Ltd. ANTIBODY AGAINTS α-CHAIN OF HUMAN INTERLEUKIN 5 RECEPTOR
US7455964B1 (en) 1996-07-15 2008-11-25 The Hospital For Sick Children Genes from the 20q13 amplicon and their uses
US7049424B2 (en) 1996-07-15 2006-05-23 The Regents Of The University Of California Genes from the 20Q13 amplicon and their uses
AU1690697A (en) * 1996-01-17 1997-08-11 Schering Corporation Baculovirus expression system for human interleukin 5 receptor and method of screening for interleukin antagonists
US5861279A (en) * 1996-01-17 1999-01-19 Schering Corporation Baculovirus expression system for human interleukin 5 receptor and method of screening for interleukin 5 antagonists
FR2783326B1 (fr) * 1998-09-10 2000-12-01 Immunotech Sa Procede de detection ou de quantification des basophiles et des eosinophiles
US7109299B1 (en) 1999-12-16 2006-09-19 Affymax, Inc. Peptides and compounds that bind to the IL-5 receptor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5453491A (en) * 1990-09-11 1995-09-26 Kiyoshi Takatsu Murine interleukin-5 receptor

Also Published As

Publication number Publication date
FI916067A7 (fi) 1992-06-28
KR920012440A (ko) 1992-07-27
NZ241094A (en) 1993-07-27
EP0492214A3 (en) 1992-09-09
MX9102767A (es) 1992-06-30
HU913961D0 (en) 1992-02-28
JP2554418B2 (ja) 1996-11-13
FI916067A0 (fi) 1991-12-20
EP0492214A2 (en) 1992-07-01
AU8998591A (en) 1992-10-15
FI916067L (fi) 1992-06-28
IE914548A1 (en) 1992-07-01
AR246310A1 (es) 1994-07-29
PT99929A (pt) 1993-01-29
CA2058003A1 (en) 1992-06-28
YU199691A (sh) 1994-06-24
AU647560B2 (en) 1994-03-24
JPH0678772A (ja) 1994-03-22
HUT59725A (en) 1992-06-29
NO915084D0 (no) 1991-12-23
IL100470A0 (en) 1992-09-06
TW280833B (en:Method) 1996-07-11

Similar Documents

Publication Publication Date Title
NO914541L (no) Fremgangsmaate ved fremstilling av tumor-nekrose-faktor-muteiner
NO915084L (no) Fremgangsmaate ved fremstilling av human interleukin-5 receptor
ES2225840T3 (es) Utilizacion de factores de crecimiento de fibroblasto para estimular el crecimiento oseo.
KR900700508A (ko) 인간의 호흡기 합포체성 바이러스에 대한 당단백질 면역 단편을 함유하는 키메라(chimeric) 당단백질
ATE365796T1 (de) Tumornekrosefaktor-rezeptoren 6 alpha& 6 beta
DE69230993D1 (de) Rekombinante viren vektoren zur expression in muskelzellen
ES2255713T3 (es) Factor neurotrofico que se deriva de lineas celulares truncadas gliales.
DK0689449T3 (da) Præparater til anvendelse i humanterapi, kendetegnet ved kombination af et muramylpeptid med en cytokin
EP0278776A3 (en) Methods and deoxyribonucleic acid for the preparation of tissue factor protein
ES2073571T3 (es) Aplicacion de nuevos fragmentos de adn como secuencia que codifica un peptido señal para la secrecion de proteinas maduras, mediante levaduras recombinantes, cassettes de expresion, levaduras transformadas y procedimiento correspondiente de preparacion de proteinas.
NZ279963A (en) Human tissue inhibitor of metalloproteinase-4 (timp-4) and dna (rna) encoding polypeptide which may be derived from atcc 75946
DK304488D0 (da) Borholdige peptider eller fysiologisk acceptable salte deraf og deres anvendelse samt mellemprodukter til dens fremstilling
DE10399023I1 (de) TFN-bindende Proteine
DK75694A (da) Tumornecrosefaktor og derivater og mutantformer deraf, fremgangsmåde til fremstilling deraf, DNA som koder derfor, replicerbar udtrykkelsesvektor indeholdende DNA'en og celle transformeret dermed samt præparater omfattende tumornecrosefaktoren
BR0008161A (pt) Uso de uma composição terapêutica para tratamento de uma célula tumoral, composição terapêutica, e kit para tratamento de uma célula tumoral
NZ505063A (en) Pharmaceutical use of long pentraxin PTX3 in treating tumour conditions
DE3853139D1 (de) Rekombinanter, fremde gene enthaltender menschlicher cytomegalovirus und seine verwendung.
DE69534180D1 (de) Promotor der tie rezeptor protein kinase
ATE101200T1 (de) Impfstoffe gegen menschliche respiratorische viren.
NO965431D0 (no) Höy-affinitet melatoninreseptorer og anvendelser derav
ATE270333T1 (de) Von proteinen des hepatitis c-virus abgeleitete polypeptide und deren verwendung
PT667872E (pt) Interleucina-6 mutante com actividade biologica melhorada em relacao a da interleucina 6 selvagem
NO890932D0 (no) Modifiserte proteiner.
Cioni et al. Transdifferentiation of larval Xenopus laevis iris under the influence of the pituitary
BR9806755A (pt) Molécula de dna recombinante, célula hospedeira, métodos para prolongar a sobrevivência de enxerto de tecido, para aumentar a resposta à terapia exógena por interferon no tratamento de câncer e para fornecer uma proteìna de ligação de receptor ifnar!, e, proteìna de ligação-ifnar1.